# Evaluation of the Stereotactic MR-guided Adaptive Radiotherapy for Locally Advanced Pancreatic Cancers

> **NCT07097064** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Institut du Cancer de Montpellier - Val d'Aurelle** · enrollment: 160 (estimated)

## Conditions studied

- Locally Advanced Pancreatic Adenocarcinoma

## Interventions

- **COMBINATION_PRODUCT:** standard radiotherapy with chemotherapy
- **RADIATION:** MRI-guided adaptive stereotactic radiotherapy (SMART)

## Key facts

- **NCT ID:** NCT07097064
- **Lead sponsor:** Institut du Cancer de Montpellier - Val d'Aurelle
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2028-09
- **Final completion:** 2033-09
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07097064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07097064, "Evaluation of the Stereotactic MR-guided Adaptive Radiotherapy for Locally Advanced Pancreatic Cancers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07097064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*